Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
ACS Chemical Biology
|
April 29, 2015
The Effect of Halogen-to-Hydrogen Bond Substitution on Human Aldose Reductase Inhibition
Jindřich Fanfrlík, Francesc X Ruiz, Aneta Kadlčíková, et al.
JACS Au
|
August 29, 2025
Bridged Azobenzene Exhibits Fully Reversible Photocontrolled Binding to a G‑Quadruplex DNA/Duplex Junction
Javier Ramos-Soriano, Y Jennifer Jiang, Bowen Deng, et al.
European Journal of Medicinal Chemistry
|
January 1, 2017
Explicit treatment of active-site waters enhances quantum mechanical/implicit solvent scoring: Inhibition of CDK2 by new pyrazolo[1,5-a]pyrimidines
Michaela Hylsová, Benoit Carbain, Jindřich Fanfrlík, et al.
ACS Medicinal Chemistry Letters
|
June 17, 2026
Discovery of 2H-Pyrrolo[3,4‑<i>c</i>]pyridin-3-one Derivatives as Type-III c‑MET Inhibitors Enabled by Free-Energy Perturbation Calculations
Eric Therrien, Shulu Feng, Katherine Amberg-Johnson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
ACS Chemical Biology
|
April 29, 2015
The Effect of Halogen-to-Hydrogen Bond Substitution on Human Aldose Reductase Inhibition
Jindřich Fanfrlík, Francesc X Ruiz, Aneta Kadlčíková, et al.
JACS Au
|
August 29, 2025
Bridged Azobenzene Exhibits Fully Reversible Photocontrolled Binding to a G‑Quadruplex DNA/Duplex Junction
Javier Ramos-Soriano, Y Jennifer Jiang, Bowen Deng, et al.
European Journal of Medicinal Chemistry
|
January 1, 2017
Explicit treatment of active-site waters enhances quantum mechanical/implicit solvent scoring: Inhibition of CDK2 by new pyrazolo[1,5-a]pyrimidines
Michaela Hylsová, Benoit Carbain, Jindřich Fanfrlík, et al.
ACS Medicinal Chemistry Letters
|
June 17, 2026
Discovery of 2H-Pyrrolo[3,4‑<i>c</i>]pyridin-3-one Derivatives as Type-III c‑MET Inhibitors Enabled by Free-Energy Perturbation Calculations
Eric Therrien, Shulu Feng, Katherine Amberg-Johnson, et al.
Page
of 2